Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 10 of 2497 results
Sort by: relevance publication year

Targeting the Wnt signaling pathway in colorectal cancer

JOURNAL ARTICLE published 2 April 2016 in Expert Opinion on Therapeutic Targets

Authors: Masaaki Sawa | Mari Masuda | Tesshi Yamada

ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer’s disease

JOURNAL ARTICLE published 2 November 2017 in Expert Opinion on Therapeutic Targets

Research funded by Alzheimer’s Association (NIRP-14-304969) | ADR program r6esearch fellowship (A2014314F) | Progetto di Ricerca di Interesse Nazionale (PRIN2015N4FKJ4) | Università degli Studi di Milano-Bicocca (PSR2015-1716GRACA02_05_M)

Authors: Elena Marcello | Barbara Borroni | Silvia Pelucchi | Fabrizio Gardoni | Monica Di Luca

MAPKs: new targets for neurodegeneration

JOURNAL ARTICLE published April 2003 in Expert Opinion on Therapeutic Targets

Authors: Sarah J Harper | Neil Wilkie

Dickkopf-1 as a potential therapeutic target in Paget's disease of bone

JOURNAL ARTICLE published February 2010 in Expert Opinion on Therapeutic Targets

Authors: Helen S McCarthy | Michael J Marshall

Chromatin modification and muscle differentiation

JOURNAL ARTICLE published December 2006 in Expert Opinion on Therapeutic Targets

Authors: Hakima Yahi | Ophélie Philipot | Valentina Guasconi | Lauriane Fritsch | Slimane Ait-Si-Ali

Targeting the CTLA-4/B7 axes in glioblastoma: preclinical evidence and clinical interventions

JOURNAL ARTICLE published 2 November 2022 in Expert Opinion on Therapeutic Targets

Research funded by Tabriz University of Medical Sciences (68136 and 68137)

Authors: Mehrdad Fathi | Seyed-Mostafa Razavi | Mozhdeh Sojoodi | Armin Ahmadi | Farbod Ebrahimi | Afshin Namdar | Mohammad Hojjat-Farsangi | Sharareh Gholamin | Farhad Jadidi-Niaragh

Understanding the role of galectins toward influenza A virus infection

JOURNAL ARTICLE published 3 October 2023 in Expert Opinion on Therapeutic Targets

Research funded by Kaohsiung Medical University Research Foundation (KMU-M108006) | Academia and Industry Collaboration Project of Kaohsiung Medical University (#KMU-S111019)

Authors: Zih-Syuan Yang | Chih-Yen Lin | Muhammad Bilal Khan | Ming-Cheng Hsu | Wanchai Assavalapsakul | Arunee Thitithanyanont | Sheng-Fan Wang

Advances in cerebellar disorders: pre-clinical models, therapeutic targets, and challenges

JOURNAL ARTICLE published 3 October 2023 in Expert Opinion on Therapeutic Targets

Authors: Mario Manto | Jan Cendelin | Michael Strupp | Hiroshi Mitoma

Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapy

JOURNAL ARTICLE published 2 December 2023 in Expert Opinion on Therapeutic Targets

Research funded by Tehran University of Medical Sciences (40230-37-03-97)

Authors: Masoud Sotoudeh | Vahid Mansouri | Ramin Shakeri | Bahareh Sharififard | Nasim Sajadi | Vahid Haghpanah | Mahmood Naderi

ADAM33: a novel therapeutic target for asthma

JOURNAL ARTICLE published August 2003 in Expert Opinion on Therapeutic Targets

Authors: Robert M Powell | Lynnsey M Hamilton | Stephen T Holgate | Donna E Davies | John W Holloway

Calcium channelopathies in neurodegenerative disorder: an untold story of RyR and SERCA

JOURNAL ARTICLE published 2 November 2023 in Expert Opinion on Therapeutic Targets

Authors: Maanvi Dhureja | Richmond Arthur | Divya Soni | Shubham Upadhayay | Pooja Temgire | Puneet Kumar

Interleukin-18 in cancer immunology and immunotherapy

JOURNAL ARTICLE published 2 November 2023 in Expert Opinion on Therapeutic Targets

Research funded by Ministry of Economy (MINECO SAF2014-52361-R and SAF 2017-83267-C2-1 R MC)

Authors: Assunta Cirella | Irene Olivera | Carlos Luri-Rey | Elixabet Bolaños | Pedro Berraondo | Ignacio Melero

Tolperisone induces UPR-mediated tumor inhibition and synergizes with proteasome inhibitor and immunotherapy by targeting LSD1

JOURNAL ARTICLE published 2 September 2023 in Expert Opinion on Therapeutic Targets

Research funded by National Natural Science Foundation of China (82072949) | Nature Science Basic Research Program of Shaanxi (2023-JC-QN-0985)

Authors: Wei Jiang | Zhiwei Yang | Pu Chen | Man Zhao | Yubo Wang | Jingyuan Wang | Xinru Li | Meichen Wang | Peng Hou

Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer

JOURNAL ARTICLE published 2 August 2016 in Expert Opinion on Therapeutic Targets

Research funded by National Institute of Dental and Craniofacial Research (R21DE023973) | Pharmaxis Corporation, Sydney, NSW, Australia (Research Contract)

Authors: Philip C. Trackman

Targets to treat androgen excess in polycystic ovary syndrome

JOURNAL ARTICLE published 2 November 2015 in Expert Opinion on Therapeutic Targets

Authors: Manuel Luque-Ramírez | Héctor Francisco Escobar-Morreale

Therapy innovation for the treatment of pancreatic neuroendocrine tumors

JOURNAL ARTICLE published April 2012 in Expert Opinion on Therapeutic Targets

Authors: Ferdinando Riccardi | Mimma Rizzo | Lucia Festino | Francesca Ambrosio | Carlo Molino | Generoso Uomo | Giacomo Cartenì

Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?

JOURNAL ARTICLE published 2 December 2015 in Expert Opinion on Therapeutic Targets

Authors: Antonio Gnoni | Daniele Santini | Mario Scartozzi | Antonio Russo | Antonella Licchetta | Vincenzo Palmieri | Luigi Lupo | Luca Faloppi | Giuseppe Palasciano | Vincenzo Memeo | Gioacchino Angarano | Oronzo Brunetti | Attilio Guarini | Salvatore Pisconti | Vito Lorusso | Nicola Silvestris

Targeting the PI3K and MAPK pathways to treat Kaposi’s sarcoma-associated herpes virus infection and pathogenesis

JOURNAL ARTICLE published May 2007 in Expert Opinion on Therapeutic Targets

Authors: Phelps J Lambert | Aniqa Z Shahrier | Audy G Whitman | Ossie F Dyson | Adrian J Reber | James A McCubrey | Shaw M Akula

Targeting oxidative stress in cancer

JOURNAL ARTICLE published November 2010 in Expert Opinion on Therapeutic Targets

Authors: Matthew W Lawless | Kenneth J O'Byrne | Steven G Gray

FGF2: a novel druggable target for glioblastoma?

JOURNAL ARTICLE published 2 April 2020 in Expert Opinion on Therapeutic Targets

Authors: Ana Jimenez-Pascual | Kelly Mitchell | Florian A Siebzehnrubl | Justin D Lathia